In accordance
with 5 CFR 1320, this information collection is approved for 3
years. Previous TOC have been satisfied.
Inventory as of this Action
Requested
Previously Approved
06/30/2018
36 Months From Approved
06/30/2015
1,046
0
1,484
123
0
272
6,227
0
331,199
The Controlled Substances Act requires
practitioners conducting narcotic treatment to register annually
with DEA. 21 U.S.C. 822, 823(g)(1); 21 CFR 1301.11, 1301.13.
Registration is a necessary control measure that prevents diversion
by ensuring the closed system of distribution of controlled
substances can be monitored by DEA and that the businesses and
individuals handling controlled substances are qualified to do so
and are accountable.
US Code:
21
USC 822 Name of Law: Persons required to register
US Code: 21
USC 823 Name of Law: Registration Requirements
In prior information collection
requests, the associated registration fee was included in the cost
burden calculation. The DEA believes the registration fee should be
excluded from the information collection cost burden because the
time and capital expense burden to provide the information is not
tied to the registration fee. This change in calculation method is
employed in this and future information collection requests.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.